Search Results

There are 51010 results for: content related to: Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer

  1. Abstracts

    International Journal of Gynecological Cancer

    Volume 14, Issue s1, September 2004, Pages: 1–249,

    Article first published online : 13 SEP 2004, DOI: 10.1111/j.1525-1438.2004.1315431.x

  2. A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 79–85, M.R. VALERIO, P. TAGLIAFERRI, F. RASPAGLIESI, F. FULFARO, G. BADALAMENTI, C. ARCARA, G. CICERO, A. RUSSO, S. VENUTA, G. GUARNERI and N. GEBBIA

    Article first published online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00324.x

  3. Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 1, March 2010, Pages: 66–73, Rachel F DEAR, Bo GAO and Paul HARNETT

    Article first published online : 26 JAN 2010, DOI: 10.1111/j.1743-7563.2009.01263.x

  4. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Article first published online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  5. Treatment of recurrent disease: randomized trials of monotherapy versus combination chemotherapy

    International Journal of Gynecological Cancer

    Volume 15, Issue s3, November 2005, Pages: 241–246, A. GONZÁLEZ-MARTÍN and GEICO Group

    Article first published online : 18 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00436.x

  6. You have free access to this content
    Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

    Intervention Review

    The Cochrane Library

    Theresa A Lawrie, Andrew Bryant, Alison Cameron, Emma Gray and Jo Morrison

    Published Online : 9 JUL 2013, DOI: 10.1002/14651858.CD006910.pub2

  7. Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma

    International Journal of Gynecological Cancer

    Volume 15, Issue s1, May 2005, Pages: 18–22, P. G. Rose

    Article first published online : 11 APR 2005, DOI: 10.1111/j.1525-1438.2005.15357.x

  8. Review of gemcitabine-based combinations for platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue s1, May 2005, Pages: 23–30, J. Sehouli

    Article first published online : 11 APR 2005, DOI: 10.1111/j.1525-1438.2005.15353.x

  9. Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

    Journal of Surgical Oncology

    Volume 72, Issue 3, November 1999, Pages: 162–169, Sharad A. Ghamande and M. Steven Piver

    Article first published online : 15 NOV 1999, DOI: 10.1002/(SICI)1096-9098(199911)72:3<162::AID-JSO9>3.0.CO;2-0

  10. Second-line randomized trials in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue s1, March/April 2008, Pages: 59–66, J.B. VERMORKEN

    Article first published online : 2 SEP 2008, DOI: 10.1111/j.1525-1438.2007.01161.x

  11. You have free access to this content
    A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3283–3293, Angeles Alvarez Secord, Andrew Berchuck, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Larry E. Puls, Robert W. Holloway, George S. Lewandowski, Fidel A. Valea and Laura J. Havrilesky

    Article first published online : 9 NOV 2011, DOI: 10.1002/cncr.26610

  12. You have free access to this content
    Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer

    Cancer

    Volume 118, Issue 3, 1 February 2012, Pages: 689–697, Nicole D. Fleming, Hasmik Agadjanian, Hoorig Nassanian, Carl W. Miller, Sandra Orsulic, Beth Y. Karlan and Christine S. Walsh

    Article first published online : 12 JUL 2011, DOI: 10.1002/cncr.26329

  13. You have free access to this content
    Population pharmacokinetic–pharmacodynamic analysis for eribulin mesilate-associated neutropenia

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 412–424, J. G. Coen van Hasselt, Anubha Gupta, Ziad Hussein, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Article first published online : 20 AUG 2013, DOI: 10.1111/bcp.12143

  14. Is combination chemotherapy superior to single-agent chemotherapy in second-line treatment?

    International Journal of Gynecological Cancer

    Volume 13, Issue s2, November 2003, Pages: 185–191, A. González-Martín

    Article first published online : 18 DEC 2003, DOI: 10.1111/j.1525-1438.2003.13361.x

  15. Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 6, November/December 2008, Pages: 1194–1199, T.T. NGUYEN, J.D. WRIGHT, M.A. POWELL, R.K. GIBB, J.S. RADER, J.E. ALLSWORTH and D.G. MUTCH

    Article first published online : 23 JAN 2008, DOI: 10.1111/j.1525-1438.2007.01184.x

  16. Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers

    Journal of Obstetrics and Gynaecology Research

    Volume 36, Issue 4, August 2010, Pages: 764–768, Tomoko Goto, Masashi Takano, Rie Ohishi, Norihiro Iwasa, Motohiro Shimizu, Kosei Hasegawa, Shoji Nagao and Keiichi Fujiwara

    Article first published online : 24 JUN 2010, DOI: 10.1111/j.1447-0756.2010.01217.x

  17. Oral Presentations

    International Journal of Gynecological Cancer

    Volume 15, Issue s2, September 2005, Pages: 51–80,

    Article first published online : 24 SEP 2008, DOI: 10.1111/j.1525-1438.2005.t01-3-.x

  18. Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 60–67, L. FUSO, F. AMANT, P. NEVEN, P. BERTELOOT and I. VERGOTE

    Article first published online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00315.x

  19. The role of anthracyclines in second-line therapy of ovarian cancer

    International Journal of Gynecological Cancer

    Volume 13, Issue s2, November 2003, Pages: 178–184, J. B. Vermorken

    Article first published online : 18 DEC 2003, DOI: 10.1111/j.1525-1438.2003.13364.x

  20. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

    International Journal of Gynecological Cancer

    Volume 17, Issue 2, March/April 2007, Pages: 359–366, P. HARNETT, M. BUCK, P. BEALE, A. GOLDRICK, S. ALLAN, B. FITZHARRIS, P. De SOUZA, M. LINKS, G. KALIMI, T. DAVIES and R. STUART-HARRIS

    Article first published online : 11 JAN 2007, DOI: 10.1111/j.1525-1438.2007.00763.x